xenon has been researched along with mci 9038 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Maruki, Y; Matsuzaki, M; Narabayashi, Y; Onoda, A; Sawada, M; Shimazu, K | 1 |
| Fudaba, H; Hayashida, O; Nagamitsu, T; Nagatsuna, T; Wakuta, Y; Yamashita, T | 1 |
1 trial(s) available for xenon and mci 9038
| Article | Year |
|---|---|
The regional cerebral blood flow amelioration of argatroban in the acute stage of cerebral thrombosis.
Topics: Acute Disease; Adult; Aged; Antithrombins; Arginine; Cerebrovascular Circulation; Female; Humans; Intracranial Thrombosis; Male; Middle Aged; Pipecolic Acids; Sulfonamides; Tomography, X-Ray Computed; Xenon | 2000 |
1 other study(ies) available for xenon and mci 9038
| Article | Year |
|---|---|
A specific thrombin inhibitor (argatroban) ameliorated cerebral blood flow in the patients with acute cerebral infarction.
Topics: Aged; Aged, 80 and over; Animals; Antithrombins; Arginine; Cerebral Infarction; Cerebrovascular Circulation; Female; Humans; Male; Middle Aged; Pipecolic Acids; Sulfonamides; Tomography, X-Ray Computed; Xenon | 2000 |